• Info
  • Insider Ownership

Insider Trading & Ownership of George D. Yancopoulos

Location
Tarrytown, NY
Summary
The estimated net worth of George D. Yancopoulos is at least $804,491,660 dollars as of 05 Jan 2026. George D. Yancopoulos is the Bd. Co-Chair, President & CSO, Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $804.49M.
Signature
By: Richard Gluckselig as attorney-in-fact For: George D. Yancopoulos
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow George D. Yancopoulos and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • George D. Yancopoulos has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $804,491,660.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: REGENERON PHARMACEUTICALS, INC. ($804,491,660).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of George D. Yancopoulos

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
REGN REGENERON PHARMACEUTICALS, INC. Bd. Co-Chair, President & CSO, Director $804,491,660 31 Dec 2025

Insider Transactions Reported by George D. Yancopoulos:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored